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Abstract
Introduction. The main goal of this study was to examine the effect of acute intake of 3 mg/kg/body
mass (b.m.) of caffeine (CAF) on countermovement jump (CMJ) performance in recreationally trained
women habituated to CAF. Material and Methods. 17 healthy recreationally trained women habitually
using CAF participated in the study. The experiment followed randomized, cross-over, double-blind design
under three different conditions: control test (CONT) or consumed placebo (PLAC) or consumed 3 mg/
kg/b.m. of CAF (CAF-3). Each participant performed 2 sets of 2 CMJ. The following variables were
recorded: concentric peak velocity (PV), peak power (PP) and jump height (JH). Results. The two-way
repeated measure ANOVA (substance × set) revealed no statistically significant interaction and main
effects for all measured variables between conditions. In comparison to the CONT and PLAC, the intake
of CAF-3 was not effective at increasing PV (p = 0.533), JH (p = 0.417) and PP (p = 0.871) during 2 sets of
the CMJ. Conclusions. This study suggests that 3 mg/kg/b.m. of CAF did not improve CMJ height in
recreationally trained women habituated to CAF. Furthermore, the level of athletic performance might be
considered a factor in regard to CAF ergogenicity.
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Abstract: Introduction. The main goal of this study was to examine the effect of acute intake of 3
mg/kg/body mass (b.m.) of caffeine (CAF) on countermovement jump (CMJ) performance in recreationally trained women habituated to CAF. Material and Methods. 17 healthy recreationally trained
women habitually using CAF participated in the study. The experiment followed randomized, crossover, double-blind design under three different conditions: control test (CONT) or consumed placebo
(PLAC) or consumed 3 mg/kg/b.m. of CAF (CAF-3). Each participant performed 2 sets of 2 CMJ. The
following variables were recorded: concentric peak velocity (PV), peak power (PP) and jump height
(JH). Results. The two-way repeated measure ANOVA (substance × set) revealed no statistically significant interaction and main effects for all measured variables between conditions. In comparison to
the CONT and PLAC, the intake of CAF-3 was not effective at increasing PV (p = 0.533), JH (p = 0.417)
and PP (p = 0.871) during 2 sets of the CMJ. Conclusions. This study suggests that 3 mg/kg/b.m. of CAF
did not improve CMJ height in recreationally trained women habituated to CAF. Furthermore, the
level of athletic performance might be considered a factor in regard to CAF ergogenicity.
Keywords: ballistic exercise, ergogenic aid, female, sport performance.
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Caffeine (CAF) is a well-established ergogenic supplement, common among athletes
in many sport disciplines, and among the majority of general population [1, 2]. CAF ingestion in numerous forms [2, 3] has been shown to have an impact on exercise performance and to be beneficial in various modes of exercise, such as maximal strength, endurance and power output [4 ,5]. The ergogenic effect of CAF, particularly during anaerobic
performance is most often attributed to its ability to act as adenosine A1 and A2A receptor
antagonist [4, 6]. CAF and adenosine molecular structures are similar, hence CAF inges-
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tion results in blocking adenosine and A1 and A2A receptors binding [6, 7], inducing increased arousal, motor unit firing rates, neuro-excitability and inhibited pain perception
[4, 8].
The power output is known to be a significant component of athletic performance
and it has been shown that CAF ingestion enhances single-bout sprinting tasks (the Wingate test), ballistic tasks (jumps and throws) or resistance exercise performance [10]. Although CAF supplementation has been shown to affect power output in both male and
female subjects [8, 9, 11], it should be pointed out that the gender may be one of the factors
that plays an important role in acute CAF efficiency [11–13]. Due to the differences in
stages of the menstrual cycle as well as the use of oral contraceptives by females, CAF
metabolization speeds and thus its ergogenic effect might be altered [13,33]. Moreover, a
systematic review by Mielgo-Ayuso et al. [11] indicated a different ergogenic effect of
acute CAF intake on anaerobic performance in men from that in women (greater CAF
ergogenicity for males). Furthermore, in most of the studies analyzing CAF ergogenicity,
the majority of subjects are male, or mixed gender populations are included, thus it is not
clear whether these results translate to women or not [11–13].
Although various doses of CAF, ranging from 3 to 13 mg/kg/body mass, have been
utilized in the literature [12, 14, 15], as regards the power output, most often low (3
mg/kg/body mass) to moderate (6 mg/kg/body mass) doses are used [4,9,16]. The results
of several studies indicated that habitual use of CAF may reduce the ergogenic effects of
such doses [12, 15, 17–19]. On the other hand, different studies (related to ballistic tasks
performance) have shown that the level of daily CAF intake does not influence its ergogenicity [7, 20]. Thus, the available literature regarding the effects of habitual consumption of CAF on its ergogenicity remains inconclusive, and this issue has not been sufficiently examined, particularly in female subjects [2, 13, 20–22].
Taking into consideration that habituation to CAF may be a factor affecting its ergogenicity, and only few previous investigations included female subjects [23], the purpose
of this study was to examine the effect of acute intake of 3 mg/kg/body mass of CAF on
countermovement jump (CMJ) performance in recreationally trained women habituated
to CAF. Given that the CAF dose of 3 mg/kg/body mass is the lowest CAF dose considered
to be ergogenic [2, 12], and could be potentially used as an ergogenic aid during training
by recreationally trained females, the dose of 3 mg/kg/body mass was administered. We
hypothesized that acute CAF ingestion would enhance performance compared to both
control and placebo conditions.
2. Materials and Methods
This study used a randomized, cross-over, double-blind design in which initially a familiarization session was conducted, followed by three different experimental sessions with
a one-week rest interval between sessions to allow for complete recovery and rinsing out
the substance (Figure 1). During three experimental sessions, participants performed a control test (CONT) or consumed either placebo (PLAC) or CAF at a dose of 3 mg/kg/body mass
(CAF-3). One hour after consuming CAF-3 or PLAC, the subjects performed 2 series of 2
jumps with a 3-minute rest interval between each trial. Both CAF and PLAC were administered orally one hour before each exercise protocol to ensure the maximum concentration of
CAF in the blood and at least 2 hours after the last meal to maintain the same absorption
time of the tested substance. The CAF supplement was in the form of capsules containing
an individual dose of CAF (Caffeine Kick®, Olimp Laboratories, Dębica). The manufacturer
also supplied identical PLAC capsules filled with all-purpose flour. Participants abstained
from strenuous physical activity the day before each test, and they were also asked to maintain their training, eating and hydration habits, including regular CAF consumption during
the study period. Participants also received a list of CAF-containing products that were prohibited for consumption 12 hours prior to each trial. In addition, participants recorded their
caloric intake 24 hours prior to the start of every test procedure using the "MyfitnessPal"
program to ensure that the diet was similar before each trial.
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2.1. Participants
The study included 17 healthy recreationally trained women (age = 23.1 ± 1.0 years;
body mass = 60.2 ± 7.6 kg; height = 166.4 ±5.3 cm; body mass index (BMI) = 21.7 ± 2.1) with
at least 2 years of strength training experience (2.9 ± 0.8 years), who volunteered to participate in the study. All participants were habitual CAF consumers (3.2 ± 1.2 mg/kg/body mass;
191.6 ± 72.9 mg of CAF per day) and their reported daily ingestion of CAF was based on the
Food Frequency Questionnaire (FFQ). The inclusion criteria were as follows: (a) free from
neuromuscular and musculoskeletal disorders, (b) minimum 2 years of experience in strength
training, (c) at least low habitual consumption of CAF, as per previously proposed thresholds
for classifying individuals in sport performance research according to their habitual caffeine
consumption [24]. Participants were excluded when they suffered from any pathology or
injury. Additionally, participants were required not to take any medications or supplements
within the 3 previous months. The study protocol was approved by the Bioethics Committee
for Scientific Research at the Academy of Physical Education in Katowice, Poland (3/2019),
according to the ethical standards of the latest version of the Declaration of Helsinki, 2013.
2.2. Study Protocol
Habitual Caffeine Intake Assessment
Habitual CAF intake was measured by an adapted version of FFQ proposed by
Bühler et al. [25]. Portions, in household measures, were used to assess the amount of food
consumed according to the frequency of consumption during a day, week and month. The
list was composed of dietary products with high CAF content including different types of
coffee, tea, energy drinks, cocoa products, popular beverages, medications and caffeine
supplements. Previously published information and nutritional tables were used for database construction [26–28]. Based on the answers in FFQ, a qualified nutritionist estimated the habitual CAF intake.
Familiarization Session
The familiarization session which included the same procedures used in subsequent
experimental sessions was the first attempt at research. Study participants arrived at the
laboratory at the same time of day as for the upcoming experimental sessions (morning,
between 9:00 am and 11:00 am). Upon arrival, participants cycled on an ergometer for 5
minutes at an intensity that resulted in a heart rate of around 130 beats per minute, followed by an overall lower body warm-up containing ten bodyweight forward and lateral
lunges, squats and standing calf raises. Then, the participants performed a test trial consisting of 2 sets of 2 CMJ, with a 3-minute rest between sets, which is exactly the same as
in the other experimental sessions.
Experimental session
Three sessions were carried out during the experimental trials with one week between each trial, and the protocols were identical. All trials were conducted between 9.00
am and 11.00 am to avoid diurnal variability. The overall warm-up for the experimental
sessions was identical to that performed in the familiarization session. After the warmup, participants performed 2 sets of 2 CMJ, with 3 minutes’ rest between the sets. Each
CMJ was performed on the Force-Decks FD4000 Dual Force Platforms hardware, with
a sample rate of 1000 Hz. Previous research has shown high reliability and validity of this
force platform (intraclass correlation coefficient [ICC] = 0.944 to 0.975) for all variables
measured in this study, with jump height showing the highest coefficient of variation (CV)
(3.8%) [29]. Manufacturer's software was used for the instantaneous recording of peak
velocity, height, and peak power obtained during each CMJ under three different conditions: CONT (i.e. no ingestion of the substance) or consumed PLAC or CAF-3. Each CMJ
was performed from a standing position with a straight torso, knees fully extended with
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hands-on-iliac crest and feet shoulder-width apart. Participants dropped into the countermovement position to a self-selected depth and immediately jumped for maximum height
without arm swing. The take-off was executed as a continuous movement with no observable pause between downward and upward phases. Participants were told that the landing must be with the same position than the take-off and it should be produced on the
mid-section of the force platform. During the apex of the jump, participants kept their legs
fully extended. No instructions were given as to the amplitude or speed of the countermovement. The best jump of the two attempts was used for further analysis. The measurement was performed independently for each replicate and the following variables
were recorded: concentric peak velocity (PV, in m/s), peak power (PP, in W), and jump
height (JH, in cm). The jump height was calculated from the flight time. All participants
completed the described test protocol, which was carefully repeated in subsequent experimental sessions.

Fig. 1. Schematic representation of the study design.
CONT: control, PLAC: placebo, CAF-3: caffeine at a dose of 3 mg/kg, b.m.: body mass.

2.3. Statistical analysis
The Shapiro–Wilk test was used in order to verify the normality of the data. All data
presented a normal distribution. Verification of differences between CONT, PLAC and
CAF-3 was performed using ANOVA with repeated measures. Effect sizes (Cohen’s d) were
reported where appropriate. Parametric effect sizes (ES), were defined as large for d > 0.8, as
moderate for d between 0.8 and 0.5, and as small for d < 0.5 [30]. The statistical significance
was set at p < 0.05. All statistical analysis were performed using SPSS (version 25.0; SPSS,
Inc., Chicago, IL, USA) and were expressed as means with standard deviations (± SD).
3. Results
The two-way repeated measure ANOVA (substance × set) revealed no statistically
significant interaction and no main effects for all measured variables. In comparison to
the CONT and PLAC, the intake of CAF-3 did not improved PV (2.43 ± 0.36 vs. 2.48 ± 0.45
vs. 2.43 ± 0.3 m/s, respectively; p = 0.553; Figure 2) nor JH (27.1 ± 9.0 vs. 28.7 ± 11.5 vs. 27.2
± 7.9 cm, respectively; p = 0.417; Figure 3) and PP (2602 ± 511 vs. 2618 ± 520 vs. 2587 ± 401
W, respectively; p = 0.871; Figure 4) during 2 sets of CMJ. Additionally, small ES was found
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for all measured variables between the CONT, PLAC and CAF-3 groups, except for PV
between CONT and CAF-3, where no effects were found (Table 1).
Table 1. Values of the effect size of peak velocity, jump height and peak power during 2 sets
of CMJ with the ingestion of placebo and 3 mg/kg of caffeine or during control conditions.
Peak Velocity
[m/s]
0.12

Jump Height
[cm]
0.15

Peak Power
[W]
0.03

CONT vs CAF-3

0

0.12

0.03

PLAC vs CAF-3

0.13

0.15

0.07

Conditions
CONT vs PLAC
ES

CONT: control, PLAC: placebo, CAF-3: caffeine at a dose of 3 mg/kg, ES: effect size

Velocity [m/s]

Peak Velocity [m/s]
3,00
2,90
2,80
2,70
2,60
2,50
2,40
2,30
2,20
2,10
2,00

Peak Velocity [m/s]

CONT

PLAC

CAF-3

2,43

2,48

2,43

Fig. 2. Results of peak velocity during CMJ in the control, placebo and caffeine conditions.
CONT: control, PLAC: placebo, CAF-3: caffeine at a dose of 3 mg/kg.
Data are presented as means ± SD.

Height [cm]

Jump Height [cm]
42,0
40,0
38,0
36,0
34,0
32,0
30,0
28,0
26,0
24,0
22,0
20,0
18,0
16,0

Jump Height [cm]

CONT

PLAC

CAF-3

27,1

28,7

27,2

Fig. 3. Results of jump high during CMJ in the control, placebo and caffeine conditions
CONT: control, PLAC: placebo, CAF-3: caffeine at a dose of 3 mg/kg.
Data are presented as means ± SD.
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Power [W]

Peak Power [W]
3200
3100
3000
2900
2800
2700
2600
2500
2400
2300
2200
2100
2000

Peak Power [W]

CONT

PLAC

CAF-3

2602

2618

2587

Fig. 4. Results of peak power during CMJ in the control, placebo and caffeine conditions.
CONT: control, PLAC: placebo, CAF-3: caffeine at a dose of 3 mg/kg
Data are presented as means ± SD.

4. Discussion
Given that the available literature concerning the topic of CAF ergogenicity among
habituated women is scarce, particularly as regards power performance, the objective of
this study was to assess the impact of acute intake of CAF-3 on CMJ performance in recreationally trained women habituated to CAF. The main finding of this study was that
CAF-3 did not provide an ergogenic effect on CMJ performance compared to CONT and
PLAC condition. Therefore, the low CAF dose (CAF-3) may be considered not to be ergogenic during lower body ballistic tasks among recreationally trained women habituated
to CAF. Currently, there are several studies exploring CAF impact on muscle power, utilizing the CMJ test [8, 16, 31]. The CMJ test is considered to be a reliable and valid test for
lower body power, and it is commonly used by scientist and sport practitioners [32, 33].
Furthermore, the meta-analysis by Grigic et al. [9] showed significant ergogenic effects of
acute CAF consumption on power output, as assessed by vertical jump height. However,
the results of the current study are inconsistent with most of the previous findings, which
indicated an improvement of power output in lower body ballistic tasks after acute CAF
intake [8, 9, 34]. Although, acute CAF intake has been shown to improve CMJ performance, previous studies mostly involved male subjects [31, 35–37] or both sexes [8, 38],
thus indicating that the gender may have an impact on CAF ergogenicity during ballistic
tasks, such as CMJ. To the best of the authors’ knowledge, only few studies examined CAF
impact on CMJ performance in women [16, 34, 39]. Stojanović et al. [39] reported that CAF
dose of 3 mg/kg/body mass provided small non-significant increases in CMJ performance
in professional female basketball players. By contrast, Norum et al. [34] demonstrated that
CAF dose of 4 mg/kg/body mass significantly increased CMJ height in resistance-trained
females during the early follicular phase. In should be pointed that the phase of the menstrual cycle is a factor that might influence strength and power performance; however,
this issue has not been taken into account in other studies [34]. The aforementioned research is contrary to the present study, which included recreationally trained women, thus
suggesting that the CAF impact on CMJ performance may also be related to the level of
athletic performance [2, 4, 40]. It has been proposed in the literature that the ergogenic
effect of CAF differs between trained and untrained individuals, and such disparity may
be related to higher reliability of exercise performance (less day-to-day variation) or
greater adenosine A2a receptor densities in trained compared to untrained individuals
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[13, 27]. However, only limited data related to this topic is available; furthermore, the research provides conflicting findings. Thus, further investigation regarding this issue is
required [13].
It should be taken into account that the habituation to CAF resulting in up-regulation
of adenosine receptors may modify the physiological responses to acute CAF intake [41,
42]. Moreover, it has been suggested that application of doses higher than an individual's
daily intake may be required to achieve an ergogenic effect of CAF [5]. However, as shown
in other studies, application of higher doses of CAF in habituated subjects is not beneficial,
not only in regard to resistance exercise [17, 43] but also to ballistic tasks performance [7,
41]. Nonetheless, it should be noted that all of the aforementioned studies included male
subjects. Thus extrapolation of these findings to female subjects should be made with caution. In the present study female subjects were administered a CAF dose of 3 mg/kg/body
mass, which almost equaled their daily intake (3.2 ± 1.2 mg/kg/body mass) and did not
improve CMJ performance. However, in the study by Norum et al. [34], which produced
contrary findings, subjects’ daily CAF intake (5.4 ± 2.9 mg/kg/body mass) was greater than
the dose ingested (4 mg/kg/body mass), and still administration of CAF significantly improved the CMJ height. Therefore, these findings suggest, similarly to male subjects, that
application of CAF doses exceeding one’s daily intake might not be the sole factor impacting on ergogenicity of CAF in ballistic tasks, such as CMJ in habituated subjects [7]. In
support of this, one other study [16] found that even a higher CAF dose (6 mg/kg/body
mass) did not improve CMJ performance in female team-sport players. However, these
results may also be explained by diversified daily CAF intake among subjects (0–300
mg/day), as well as their sports level, ranging from recreational to international. Thus,
further research of CAF ergogenicity among habituated women should consider such disjunctions.
Beyond the strengths of the present study, such as the participation of female subjects
habituated to CAF, also its limitations should be considered. The current research did not
account for the use of oral contraceptives among the subjects, as well as did not take account of the phase of the menstrual cycle. Furthermore, there were no physiological measurements which could provide an explanation of the obtained results. It is noteworthy
that genetic variation between individuals may influence the magnitude of performance
improvement after CAF ingestion [5, 15]; however, no genetic assessments regarding CAF
metabolism were performed.
5. Conclusions
The results of the present study indicated that the acute intake of the CAF dose of
3 mg/kg/body mass did not improve CMJ performance in recreationally trained women
habituated to CAF. These results suggest that the level of athletic performance might be
considered a factor in regard to CAF ergogenicity. Furthermore, the administration of
higher doses of CAF may not further enhance ballistic tasks performance in recreationally
trained female habituated to CAF. However, the available literature regarding this topic
is scarce and only few studies included populations of women habituated to CAF. Thus,
further research on this issue is needed.
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